Global Circulating Tumor Cell Market Insights, Forecast to 2028

  • Report ID:245640
  • Industry Name: Medical Care
  • Publishing Date: Jul-22
  • No. of Pages: 126
                              
Circulating Tumor Cell market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type CTC Enrichment CTC Detection CTC Analysis Segment by Application Breast Cancer Prostate Cancer Colorectal Cancer Others By Company Menarini-Silicon Biosystems Qiagen?Adnagen? Clearbridge Biomedics Celsee Fluidigm ApoCell Greiner Bio-one Advanced Cell Diagnostics Aviva Biosciences Fluxion Biosciences Sysmex Epic Sciences Cynvenio CytoTrack Ikonisys Vortex BioSciences Gilupi Biocept ScreenCell ANGLE By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Circulating Tumor Cell Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 CTC Enrichment 1.2.3 CTC Detection 1.2.4 CTC Analysis 1.3 Market by Application 1.3.1 Global Circulating Tumor Cell Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Breast Cancer 1.3.3 Prostate Cancer 1.3.4 Colorectal Cancer 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Circulating Tumor Cell Market Perspective (2017-2028) 2.2 Circulating Tumor Cell Growth Trends by Region 2.2.1 Circulating Tumor Cell Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Circulating Tumor Cell Historic Market Size by Region (2017-2022) 2.2.3 Circulating Tumor Cell Forecasted Market Size by Region (2023-2028) 2.3 Circulating Tumor Cell Market Dynamics 2.3.1 Circulating Tumor Cell Industry Trends 2.3.2 Circulating Tumor Cell Market Drivers 2.3.3 Circulating Tumor Cell Market Challenges 2.3.4 Circulating Tumor Cell Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Circulating Tumor Cell Players by Revenue 3.1.1 Global Top Circulating Tumor Cell Players by Revenue (2017-2022) 3.1.2 Global Circulating Tumor Cell Revenue Market Share by Players (2017-2022) 3.2 Global Circulating Tumor Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Circulating Tumor Cell Revenue 3.4 Global Circulating Tumor Cell Market Concentration Ratio 3.4.1 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Revenue in 2021 3.5 Circulating Tumor Cell Key Players Head office and Area Served 3.6 Key Players Circulating Tumor Cell Product Solution and Service 3.7 Date of Enter into Circulating Tumor Cell Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Circulating Tumor Cell Breakdown Data by Type 4.1 Global Circulating Tumor Cell Historic Market Size by Type (2017-2022) 4.2 Global Circulating Tumor Cell Forecasted Market Size by Type (2023-2028) 5 Circulating Tumor Cell Breakdown Data by Application 5.1 Global Circulating Tumor Cell Historic Market Size by Application (2017-2022) 5.2 Global Circulating Tumor Cell Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Circulating Tumor Cell Market Size (2017-2028) 6.2 North America Circulating Tumor Cell Market Size by Type 6.2.1 North America Circulating Tumor Cell Market Size by Type (2017-2022) 6.2.2 North America Circulating Tumor Cell Market Size by Type (2023-2028) 6.2.3 North America Circulating Tumor Cell Market Share by Type (2017-2028) 6.3 North America Circulating Tumor Cell Market Size by Application 6.3.1 North America Circulating Tumor Cell Market Size by Application (2017-2022) 6.3.2 North America Circulating Tumor Cell Market Size by Application (2023-2028) 6.3.3 North America Circulating Tumor Cell Market Share by Application (2017-2028) 6.4 North America Circulating Tumor Cell Market Size by Country 6.4.1 North America Circulating Tumor Cell Market Size by Country (2017-2022) 6.4.2 North America Circulating Tumor Cell Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Circulating Tumor Cell Market Size (2017-2028) 7.2 Europe Circulating Tumor Cell Market Size by Type 7.2.1 Europe Circulating Tumor Cell Market Size by Type (2017-2022) 7.2.2 Europe Circulating Tumor Cell Market Size by Type (2023-2028) 7.2.3 Europe Circulating Tumor Cell Market Share by Type (2017-2028) 7.3 Europe Circulating Tumor Cell Market Size by Application 7.3.1 Europe Circulating Tumor Cell Market Size by Application (2017-2022) 7.3.2 Europe Circulating Tumor Cell Market Size by Application (2023-2028) 7.3.3 Europe Circulating Tumor Cell Market Share by Application (2017-2028) 7.4 Europe Circulating Tumor Cell Market Size by Country 7.4.1 Europe Circulating Tumor Cell Market Size by Country (2017-2022) 7.4.2 Europe Circulating Tumor Cell Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Circulating Tumor Cell Market Size (2017-2028) 8.2 Asia-Pacific Circulating Tumor Cell Market Size by Type 8.2.1 Asia-Pacific Circulating Tumor Cell Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Circulating Tumor Cell Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Circulating Tumor Cell Market Share by Type (2017-2028) 8.3 Asia-Pacific Circulating Tumor Cell Market Size by Application 8.3.1 Asia-Pacific Circulating Tumor Cell Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Circulating Tumor Cell Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Circulating Tumor Cell Market Share by Application (2017-2028) 8.4 Asia-Pacific Circulating Tumor Cell Market Size by Region 8.4.1 Asia-Pacific Circulating Tumor Cell Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Circulating Tumor Cell Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Circulating Tumor Cell Market Size (2017-2028) 9.2 Latin America Circulating Tumor Cell Market Size by Type 9.2.1 Latin America Circulating Tumor Cell Market Size by Type (2017-2022) 9.2.2 Latin America Circulating Tumor Cell Market Size by Type (2023-2028) 9.2.3 Latin America Circulating Tumor Cell Market Share by Type (2017-2028) 9.3 Latin America Circulating Tumor Cell Market Size by Application 9.3.1 Latin America Circulating Tumor Cell Market Size by Application (2017-2022) 9.3.2 Latin America Circulating Tumor Cell Market Size by Application (2023-2028) 9.3.3 Latin America Circulating Tumor Cell Market Share by Application (2017-2028) 9.4 Latin America Circulating Tumor Cell Market Size by Country 9.4.1 Latin America Circulating Tumor Cell Market Size by Country (2017-2022) 9.4.2 Latin America Circulating Tumor Cell Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Circulating Tumor Cell Market Size (2017-2028) 10.2 Middle East & Africa Circulating Tumor Cell Market Size by Type 10.2.1 Middle East & Africa Circulating Tumor Cell Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Circulating Tumor Cell Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Circulating Tumor Cell Market Share by Type (2017-2028) 10.3 Middle East & Africa Circulating Tumor Cell Market Size by Application 10.3.1 Middle East & Africa Circulating Tumor Cell Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Circulating Tumor Cell Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Circulating Tumor Cell Market Share by Application (2017-2028) 10.4 Middle East & Africa Circulating Tumor Cell Market Size by Country 10.4.1 Middle East & Africa Circulating Tumor Cell Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Circulating Tumor Cell Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Menarini-Silicon Biosystems 11.1.1 Menarini-Silicon Biosystems Company Details 11.1.2 Menarini-Silicon Biosystems Business Overview 11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Introduction 11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2017-2022) 11.1.5 Menarini-Silicon Biosystems Recent Developments 11.2 Qiagen?Adnagen? 11.2.1 Qiagen?Adnagen? Company Details 11.2.2 Qiagen?Adnagen? Business Overview 11.2.3 Qiagen?Adnagen? Circulating Tumor Cell Introduction 11.2.4 Qiagen?Adnagen? Revenue in Circulating Tumor Cell Business (2017-2022) 11.2.5 Qiagen?Adnagen? Recent Developments 11.3 Clearbridge Biomedics 11.3.1 Clearbridge Biomedics Company Details 11.3.2 Clearbridge Biomedics Business Overview 11.3.3 Clearbridge Biomedics Circulating Tumor Cell Introduction 11.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2017-2022) 11.3.5 Clearbridge Biomedics Recent Developments 11.4 Celsee 11.4.1 Celsee Company Details 11.4.2 Celsee Business Overview 11.4.3 Celsee Circulating Tumor Cell Introduction 11.4.4 Celsee Revenue in Circulating Tumor Cell Business (2017-2022) 11.4.5 Celsee Recent Developments 11.5 Fluidigm 11.5.1 Fluidigm Company Details 11.5.2 Fluidigm Business Overview 11.5.3 Fluidigm Circulating Tumor Cell Introduction 11.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2017-2022) 11.5.5 Fluidigm Recent Developments 11.6 ApoCell 11.6.1 ApoCell Company Details 11.6.2 ApoCell Business Overview 11.6.3 ApoCell Circulating Tumor Cell Introduction 11.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2017-2022) 11.6.5 ApoCell Recent Developments 11.7 Greiner Bio-one 11.7.1 Greiner Bio-one Company Details 11.7.2 Greiner Bio-one Business Overview 11.7.3 Greiner Bio-one Circulating Tumor Cell Introduction 11.7.4 Greiner Bio-one Revenue in Circulating Tumor Cell Business (2017-2022) 11.7.5 Greiner Bio-one Recent Developments 11.8 Advanced Cell Diagnostics 11.8.1 Advanced Cell Diagnostics Company Details 11.8.2 Advanced Cell Diagnostics Business Overview 11.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Introduction 11.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2017-2022) 11.8.5 Advanced Cell Diagnostics Recent Developments 11.9 Aviva Biosciences 11.9.1 Aviva Biosciences Company Details 11.9.2 Aviva Biosciences Business Overview 11.9.3 Aviva Biosciences Circulating Tumor Cell Introduction 11.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2017-2022) 11.9.5 Aviva Biosciences Recent Developments 11.10 Fluxion Biosciences 11.10.1 Fluxion Biosciences Company Details 11.10.2 Fluxion Biosciences Business Overview 11.10.3 Fluxion Biosciences Circulating Tumor Cell Introduction 11.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2017-2022) 11.10.5 Fluxion Biosciences Recent Developments 11.11 Sysmex 11.11.1 Sysmex Company Details 11.11.2 Sysmex Business Overview 11.11.3 Sysmex Circulating Tumor Cell Introduction 11.11.4 Sysmex Revenue in Circulating Tumor Cell Business (2017-2022) 11.11.5 Sysmex Recent Developments 11.12 Epic Sciences 11.12.1 Epic Sciences Company Details 11.12.2 Epic Sciences Business Overview 11.12.3 Epic Sciences Circulating Tumor Cell Introduction 11.12.4 Epic Sciences Revenue in Circulating Tumor Cell Business (2017-2022) 11.12.5 Epic Sciences Recent Developments 11.13 Cynvenio 11.13.1 Cynvenio Company Details 11.13.2 Cynvenio Business Overview 11.13.3 Cynvenio Circulating Tumor Cell Introduction 11.13.4 Cynvenio Revenue in Circulating Tumor Cell Business (2017-2022) 11.13.5 Cynvenio Recent Developments 11.14 CytoTrack 11.14.1 CytoTrack Company Details 11.14.2 CytoTrack Business Overview 11.14.3 CytoTrack Circulating Tumor Cell Introduction 11.14.4 CytoTrack Revenue in Circulating Tumor Cell Business (2017-2022) 11.14.5 CytoTrack Recent Developments 11.15 Ikonisys 11.15.1 Ikonisys Company Details 11.15.2 Ikonisys Business Overview 11.15.3 Ikonisys Circulating Tumor Cell Introduction 11.15.4 Ikonisys Revenue in Circulating Tumor Cell Business (2017-2022) 11.15.5 Ikonisys Recent Developments 11.16 Vortex BioSciences 11.16.1 Vortex BioSciences Company Details 11.16.2 Vortex BioSciences Business Overview 11.16.3 Vortex BioSciences Circulating Tumor Cell Introduction 11.16.4 Vortex BioSciences Revenue in Circulating Tumor Cell Business (2017-2022) 11.16.5 Vortex BioSciences Recent Developments 11.17 Gilupi 11.17.1 Gilupi Company Details 11.17.2 Gilupi Business Overview 11.17.3 Gilupi Circulating Tumor Cell Introduction 11.17.4 Gilupi Revenue in Circulating Tumor Cell Business (2017-2022) 11.17.5 Gilupi Recent Developments 11.18 Biocept 11.18.1 Biocept Company Details 11.18.2 Biocept Business Overview 11.18.3 Biocept Circulating Tumor Cell Introduction 11.18.4 Biocept Revenue in Circulating Tumor Cell Business (2017-2022) 11.18.5 Biocept Recent Developments 11.19 ScreenCell 11.19.1 ScreenCell Company Details 11.19.2 ScreenCell Business Overview 11.19.3 ScreenCell Circulating Tumor Cell Introduction 11.19.4 ScreenCell Revenue in Circulating Tumor Cell Business (2017-2022) 11.19.5 ScreenCell Recent Developments 11.20 ANGLE 11.20.1 ANGLE Company Details 11.20.2 ANGLE Business Overview 11.20.3 ANGLE Circulating Tumor Cell Introduction 11.20.4 ANGLE Revenue in Circulating Tumor Cell Business (2017-2022) 11.20.5 ANGLE Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Circulating Tumor Cell Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of CTC Enrichment Table 3. Key Players of CTC Detection Table 4. Key Players of CTC Analysis Table 5. Global Circulating Tumor Cell Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Circulating Tumor Cell Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Circulating Tumor Cell Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Circulating Tumor Cell Market Share by Region (2017-2022) Table 9. Global Circulating Tumor Cell Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Circulating Tumor Cell Market Share by Region (2023-2028) Table 11. Circulating Tumor Cell Market Trends Table 12. Circulating Tumor Cell Market Drivers Table 13. Circulating Tumor Cell Market Challenges Table 14. Circulating Tumor Cell Market Restraints Table 15. Global Circulating Tumor Cell Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Circulating Tumor Cell Revenue Share by Players (2017-2022) Table 17. Global Top Circulating Tumor Cell by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell as of 2021) Table 18. Ranking of Global Top Circulating Tumor Cell Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cell Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Circulating Tumor Cell Product Solution and Service Table 22. Date of Enter into Circulating Tumor Cell Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Circulating Tumor Cell Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Circulating Tumor Cell Revenue Market Share by Type (2017-2022) Table 26. Global Circulating Tumor Cell Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Circulating Tumor Cell Revenue Market Share by Type (2023-2028) Table 28. Global Circulating Tumor Cell Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Circulating Tumor Cell Revenue Share by Application (2017-2022) Table 30. Global Circulating Tumor Cell Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Circulating Tumor Cell Revenue Share by Application (2023-2028) Table 32. North America Circulating Tumor Cell Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Circulating Tumor Cell Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Circulating Tumor Cell Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Circulating Tumor Cell Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Circulating Tumor Cell Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Circulating Tumor Cell Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Circulating Tumor Cell Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Circulating Tumor Cell Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Circulating Tumor Cell Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Circulating Tumor Cell Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Circulating Tumor Cell Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Circulating Tumor Cell Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Circulating Tumor Cell Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Circulating Tumor Cell Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Circulating Tumor Cell Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Circulating Tumor Cell Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Circulating Tumor Cell Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Circulating Tumor Cell Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Circulating Tumor Cell Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Circulating Tumor Cell Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Circulating Tumor Cell Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Circulating Tumor Cell Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Circulating Tumor Cell Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Circulating Tumor Cell Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Circulating Tumor Cell Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Circulating Tumor Cell Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Circulating Tumor Cell Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Circulating Tumor Cell Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Circulating Tumor Cell Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Circulating Tumor Cell Market Size by Country (2023-2028) & (US$ Million) Table 62. Menarini-Silicon Biosystems Company Details Table 63. Menarini-Silicon Biosystems Business Overview Table 64. Menarini-Silicon Biosystems Circulating Tumor Cell Product Table 65. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 66. Menarini-Silicon Biosystems Recent Developments Table 67. Qiagen?Adnagen? Company Details Table 68. Qiagen?Adnagen? Business Overview Table 69. Qiagen?Adnagen? Circulating Tumor Cell Product Table 70. Qiagen?Adnagen? Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 71. Qiagen?Adnagen? Recent Developments Table 72. Clearbridge Biomedics Company Details Table 73. Clearbridge Biomedics Business Overview Table 74. Clearbridge Biomedics Circulating Tumor Cell Product Table 75. Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 76. Clearbridge Biomedics Recent Developments Table 77. Celsee Company Details Table 78. Celsee Business Overview Table 79. Celsee Circulating Tumor Cell Product Table 80. Celsee Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 81. Celsee Recent Developments Table 82. Fluidigm Company Details Table 83. Fluidigm Business Overview Table 84. Fluidigm Circulating Tumor Cell Product Table 85. Fluidigm Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 86. Fluidigm Recent Developments Table 87. ApoCell Company Details Table 88. ApoCell Business Overview Table 89. ApoCell Circulating Tumor Cell Product Table 90. ApoCell Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 91. ApoCell Recent Developments Table 92. Greiner Bio-one Company Details Table 93. Greiner Bio-one Business Overview Table 94. Greiner Bio-one Circulating Tumor Cell Product Table 95. Greiner Bio-one Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 96. Greiner Bio-one Recent Developments Table 97. Advanced Cell Diagnostics Company Details Table 98. Advanced Cell Diagnostics Business Overview Table 99. Advanced Cell Diagnostics Circulating Tumor Cell Product Table 100. Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 101. Advanced Cell Diagnostics Recent Developments Table 102. Aviva Biosciences Company Details Table 103. Aviva Biosciences Business Overview Table 104. Aviva Biosciences Circulating Tumor Cell Product Table 105. Aviva Biosciences Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 106. Aviva Biosciences Recent Developments Table 107. Fluxion Biosciences Company Details Table 108. Fluxion Biosciences Business Overview Table 109. Fluxion Biosciences Circulating Tumor Cell Product Table 110. Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 111. Fluxion Biosciences Recent Developments Table 112. Sysmex Company Details Table 113. Sysmex Business Overview Table 114. Sysmex Circulating Tumor Cell Product Table 115. Sysmex Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 116. Sysmex Recent Developments Table 117. Epic Sciences Company Details Table 118. Epic Sciences Business Overview Table 119. Epic Sciences Circulating Tumor Cell Product Table 120. Epic Sciences Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 121. Epic Sciences Recent Developments Table 122. Cynvenio Company Details Table 123. Cynvenio Business Overview Table 124. Cynvenio Circulating Tumor Cell Product Table 125. Cynvenio Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 126. Cynvenio Recent Developments Table 127. CytoTrack Company Details Table 128. CytoTrack Business Overview Table 129. CytoTrack Circulating Tumor Cell Product Table 130. CytoTrack Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 131. CytoTrack Recent Developments Table 132. Ikonisys Company Details Table 133. Ikonisys Business Overview Table 134. Ikonisys Circulating Tumor Cell Product Table 135. Ikonisys Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 136. Ikonisys Recent Developments Table 137. Vortex BioSciences Company Details Table 138. Vortex BioSciences Business Overview Table 139. Vortex BioSciences Circulating Tumor Cell Product Table 140. Vortex BioSciences Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 141. Vortex BioSciences Recent Developments Table 142. Gilupi Company Details Table 143. Gilupi Business Overview Table 144. Gilupi Circulating Tumor Cell Product Table 145. Gilupi Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 146. Gilupi Recent Developments Table 147. Biocept Company Details Table 148. Biocept Business Overview Table 149. Biocept Circulating Tumor Cell Product Table 150. Biocept Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 151. Biocept Recent Developments Table 152. ScreenCell Company Details Table 153. ScreenCell Business Overview Table 154. ScreenCell Circulating Tumor Cell Product Table 155. ScreenCell Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 156. ScreenCell Recent Developments Table 157. ANGLE Company Details Table 158. ANGLE Business Overview Table 159. ANGLE Circulating Tumor Cell Product Table 160. ANGLE Revenue in Circulating Tumor Cell Business (2017-2022) & (US$ Million) Table 161. ANGLE Recent Developments Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Global Circulating Tumor Cell Market Share by Type: 2021 VS 2028 Figure 2. CTC Enrichment Features Figure 3. CTC Detection Features Figure 4. CTC Analysis Features Figure 5. Global Circulating Tumor Cell Market Share by Application: 2021 VS 2028 Figure 6. Breast Cancer Case Studies Figure 7. Prostate Cancer Case Studies Figure 8. Colorectal Cancer Case Studies Figure 9. Others Case Studies Figure 10. Circulating Tumor Cell Report Years Considered Figure 11. Global Circulating Tumor Cell Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Circulating Tumor Cell Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Circulating Tumor Cell Market Share by Region: 2021 VS 2028 Figure 14. Global Circulating Tumor Cell Market Share by Players in 2021 Figure 15. Global Top Circulating Tumor Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Circulating Tumor Cell Revenue in 2021 Figure 17. North America Circulating Tumor Cell Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Circulating Tumor Cell Market Size Market Share by Type (2017-2028) Figure 19. North America Circulating Tumor Cell Market Size Market Share by Application (2017-2028) Figure 20. North America Circulating Tumor Cell Market Size Share by Country (2017-2028) Figure 21. United States Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Circulating Tumor Cell Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Circulating Tumor Cell Market Size Market Share by Type (2017-2028) Figure 25. Europe Circulating Tumor Cell Market Size Market Share by Application (2017-2028) Figure 26. Europe Circulating Tumor Cell Market Size Share by Country (2017-2028) Figure 27. Germany Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Circulating Tumor Cell Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Circulating Tumor Cell Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Circulating Tumor Cell Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Circulating Tumor Cell Market Size Share by Region (2017-2028) Figure 37. China Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Circulating Tumor Cell Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Circulating Tumor Cell Market Size Market Share by Type (2017-2028) Figure 45. Latin America Circulating Tumor Cell Market Size Market Share by Application (2017-2028) Figure 46. Latin America Circulating Tumor Cell Market Size Share by Country (2017-2028) Figure 47. Mexico Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Circulating Tumor Cell Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Circulating Tumor Cell Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Circulating Tumor Cell Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Circulating Tumor Cell Market Size Share by Country (2017-2028) Figure 53. Turkey Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Circulating Tumor Cell Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 57. Qiagen?Adnagen? Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 58. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 59. Celsee Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 60. Fluidigm Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 61. ApoCell Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 62. Greiner Bio-one Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 63. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 64. Aviva Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 65. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 66. Sysmex Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 67. Epic Sciences Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 68. Cynvenio Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 69. CytoTrack Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 70. Ikonisys Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 71. Vortex BioSciences Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 72. Gilupi Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 73. Biocept Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 74. ScreenCell Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 75. ANGLE Revenue Growth Rate in Circulating Tumor Cell Business (2017-2022) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.